Yazar "Çetin, Bülent" için listeleme
-
Can we predict the sites of the recurrence of Ovarian cancer by F-18 FDG PET/CT depending on CA-125 level?
Turgut, Bülent; Çiftçi, Esra; Ertürk, Seyit Ahmet; Çetin, Bülent; Aker, Handan; Hasbek, Zekiye (Bentham Science Publ Ltd, 2017)Objectives: the purpose of the study is predicting the sites of the recurrence with PET/CT by serum CA-125 level and detecting the cut-off value of CA-125 for metastatic ovarian cancer (OC) in comparison with Fluorine-18 ... -
Can you draw the picture of happiness- Treatment of a young woman with breast cancer during the COVID-19 pandemic
Çetin, Bülent; Rakıcı, Sema; Gümüşay, Özge (Elsevier, 2020)40-year-old painter with breast cancer patient came to our clinic one month ago. The patient had a tachycardia and she was breathing rapidly, but there was no fever or anything else. All evidence pointed to extreme anxiety. ... -
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme
Çetin, Bülent; Gönül, İpek Işık; Gumusay, Özge; Bilgetekin, İrem; Algın, Efnan; Özet, Ahmet; Üner, Aytuğ (Wiley, 2018)The identification of prognostic factors in patients with glioblastoma multiforme (GBM) represents an area of increasing interest. Carbonic anhydrase IX (CA-IX), a hypoxia marker, correlates with tumor progression in a ... -
Classic Kaposi's sarcoma: A review of 156 cases
Çetin, Bülent; Aktaş, Bilge; Bal, Öznur; Algın, Efnan; Akman, Tülay; Koral, Lokman; Kaplan, Mehmet Ali; Demirci, Umut; Uncu, Doğan; Özet, Ahmet (Elsevier Taiwan, 2018)Background: Kaposi's sarcoma (KS) is a reactive, multifocal, multicentric, angiogenic neoplastic proliferation that is thought to originate from endothelial cells that are infected with human herpesvirus-8 (HHV-8). This ... -
HER2/neu as target in gastric adenocarcinoma
Çetin, Bülent; Özet, Ahmet (Ame Publ Co, 2016)Gastric adenocarcinoma (GAC), a heterogeneous disease characterized by epidemiologic and histopathologic differences across countries, is a leading cause of cancer-related death. -
Intravascular large B-cell lymphoma of the gallbladder
Intravascular large B-cell lymphoma (IVLBCL) is a rare type of extranodal B-cell lymphoma characterized by the growth of lymphoma cells within the lumina of small vessels. Two major patterns of clinical presentation ... -
Managing synchronous liver metastases in colorectal cancer
Çetin, Bülent; Bilgetekin, İrem; Cengiz, Mustafa; Özet, Ahmet (Springer India, 2018)The most common site of blood-borne metastases from colorectal cancers (CRC) is the liver. Resection of (liver) metastases is a part of standard treatment of metastatic colorectal cancer. Hepatic resection is the first-line ... -
Pazopanib-induced hepatotoxicity in an experimental rat model
Çetin, Bülent; Yılmaz, Güldal Esendağlı; Armağan, Berkan; Afşar, Barış; Demirci, Umut; Gülbahar, Özlem; Gümüşsoy, Özge; Bilgetekin, İrem; Özet, Ahmet; Üner, Aytuğ (Karger, 2018)Pazopanib is an effective treatment for advanced renal cell carcinoma and soft tissue sarcoma. Besides classical adverse events of this drug class, hepatotoxicity has been described as a frequent side effect. the aim of ... -
Retinal metastases from anaplastic astrocytoma
Gökmen, Onur; Çetin, Bülent; Şentürk, Senem (Elsevier Science Inc, 2017)..... -
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
Kahraman, Seda; Erul, Enes; Seyyar, Mustafa; Gümüşay, Özge; Bayram, Ertuğrul; Demirel, Burçin Çakan; Acar, Ömer; Aksoy, Sercan; Baytemur, Nazife Köse; Şahin, Elif; Çabuk, Devrim; Başaran, Gül; Paydaş, Semra; Yaren, Arzu; Güven, Deniz Can; Erdoğan, Atike Pınar; Demirci, Umut; Yaşar, Alper; Bayoğlu, İbrahim Vedat; Hızal, Mutlu; Gülbağcı, Mutlu; Paksoy, Nail; Davarcı, Sena Ece; Yılmaz, Funda; Doğan, Özlem; Orhan, Sibel Oyucu; Kayıkcıoğlu, Erkan; Aytaç, Ali; Keskinkılıç, Merve; Moçan, Eda Eylemer; Ünal, Ölçün Ümit; Aydın,Esra; Yücel, Hakan; Işık, Deniz; Eren, Önder; Uluç, Başak Oyan; Özçelik, Melike; Hacıbekiroğlu, İlhan; Aydıner, Adnan; Demir, Hacer; Öksüzoğlu, Berna; Çılbır, Ebru; Çubukçu, Erdem; Çetin, Bülent; Oktay, Esin; Erol, Cihan; Okutur, Sadi Kerem; Yıldırım, Nilgün; Alkan, Ali; Selçukbiricik, Fatih; Aksoy, Asude; Karakaş, Yusuf; Özkanlı, Gülhan; Duman, Berna Bozkurt; Aydın, Dinçer; Dulgar, Özgecan; Er, Muhammed Muhiddin; Teker, Fatih; Yavuzsen, Tuğba; Aykan, Musa Barış; İnal, Ali; İriağaç, Yakup; Kalkan, Nurhan Önal; Keser, Murat; Sakalar, Teoman; Menekşe, Serkan; Kut, Engin; Bilgin, Burak; Karaoğlanoğlu, Müge; Sunar, Veli; Özdemir, Özlem; Turhal, Nazım Serdar; Karadurmuş, Nuri; Yalçın, Bülent; Şendur, Mehmet Ali Nahit (Future Medicine Ltd, 2023)Background: Ribociclib, palbociclib and abemaciclib are currently approved CDK4/6 inhibitors along with aromatase inhibitors as the first-line standard-of-care for patients with hormone receptor-positive, HER2-negative ...